Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured...

FDA Drug Recall #D-0527-2026 — Class II — March 13, 2026

Recall Summary

Recall Number D-0527-2026
Classification Class II — Moderate risk
Date Initiated March 13, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm ENDO USA, Inc.
Location Rochester, MI
Product Type Drugs
Quantity 34,293 vials

Product Description

Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.

Reason for Recall

Presence of particulate matter: identified as Buprenorphine free base

Distribution Pattern

USA Nationwide

Lot / Code Information

Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027

Other Recalls from ENDO USA, Inc.

Recall # Classification Product Date
D-0140-2026 Class III Everolimus tablets 7.5mg, 28 tablets (each cart... Oct 10, 2025
D-0142-2026 Class III Everolimus tablets 2.5 mg, 28 tablets (each car... Oct 10, 2025
D-0141-2026 Class III Everolimus tablets 10 mg, 28 tablets (each cart... Oct 10, 2025
D-0139-2026 Class III Everolimus tablets 5mg, 28 tablets (each carton... Oct 10, 2025
D-0026-2026 Class III Everolimus tablets 5mg, 28 tablets (each carton... Sep 5, 2025

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.